SEMINARS IN THROMBOSIS, THROMBOLYSIS, AND VASCULAR BIOLOGY .6. PROCOAGULANT STATES

被引:3
作者
BECKER, RC
机构
[1] Thrombosis Research Center, Division of Cardiology, University of Massachusetts Medical Center, Worcester, MA
关键词
CARDIOVASCULAR SYSTEM; PROCOAGULANT STATES; THROMBOSIS;
D O I
10.1159/000174979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Under normal physiologic conditions, blood flows freely within the coronary arteries and peripheral vasculature, providing oxygen and essential nutriments to vital organs and metabolically active tissues. The natural thromboresistant properties of the vascular endothelium and circulating blood components provide the ideal environment for this fundamental, life-sustaining process. While hemostasis is a vital defense mechanism, preventing blood loss and ensuring rapid vessel repair, nonphysiologic thrombosis or 'hemostasis in the wrong place' may impair blood flow enough to cause debilitating or life-threatening tissue damage. Procoagulant (prothrombotic) states promote nonphysiologic thrombosis and reflect one or more significant abnormalities in either the vessel wall, circulating blood, or plasma coagulation components themselves. Although a heightened thrombotic tendency may be the end result of a focal or systemic pathologic process, in either case, thromboembolic events involving the cardiovascular system may ensue.
引用
收藏
页码:51 / 64
页数:14
相关论文
共 137 条
[1]  
ANGLESCANO E, 1979, J LAB CLIN MED, V94, P312
[2]   ABNORMAL PLASMINOGEN - HEREDITARY MOLECULAR ABNORMALITY FOUND IN A PATIENT WITH RECURRENT THROMBOSIS [J].
AOKI, N ;
MOROI, M ;
SAKATA, Y ;
YOSHIDA, N .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (05) :1186-1195
[3]   CEREBROVASCULAR-DISEASE AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, LUPUS-LIKE DISEASE, AND THE PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
GIL, A ;
VAZQUEZ, JJ ;
CHAN, O ;
BAGULEY, E ;
HUGHES, GRV .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04) :391-399
[4]  
AZA M, 1991, THROMB HAEMOSTASIS, V65, P989
[5]  
AZNAR J, 1988, BRIT HEART J, V59, P535
[6]   INTRAVENOUS NITROGLYCERIN-INDUCED HEPARIN RESISTANCE - A QUALITATIVE ANTITHROMBIN III ABNORMALITY [J].
BECKER, RC ;
CORRAO, JM ;
BOVILL, EG ;
GORE, JM ;
BAKER, SP ;
MILLER, ML ;
LUCAS, FV ;
ALPERT, JA .
AMERICAN HEART JOURNAL, 1990, 119 (06) :1254-1261
[7]   EVALUATION OF BETA-THROMBOGLOBULIN LEVELS IN CANCER-PATIENTS - EFFECTS OF ANTI-TUMOR CHEMOTHERAPY [J].
BIDET, JM ;
FERRIERE, JP ;
BESSE, G ;
CHOLLET, P ;
GAILLARD, G ;
PLAGNE, R .
THROMBOSIS RESEARCH, 1980, 19 (03) :429-433
[8]   IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES [J].
BINI, A ;
FENOGLIO, JJ ;
MESATEJADA, R ;
KUDRYK, B ;
KAPLAN, KL .
ARTERIOSCLEROSIS, 1989, 9 (01) :109-121
[9]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[10]  
BOND L, 1988, NEW ENGL J MED, V318, P121